Ticker
ARDXCompany Name
ARDELYX INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Shareholders Equity | Net Income Common Stock | Return on Equity |
---|---|---|---|
6/30/2025 | $ 139.53M | $ -56.39M | -40.41% |
3/31/2025 | $ 145.68M | $ -53.76M | -36.91% |
12/31/2024 | $ 173.29M | $ -39.14M | -22.58% |
9/30/2024 | $ 158.3M | $ -72.58M | -45.85% |
6/30/2024 | $ 146.99M | $ -65.14M | -44.32% |
3/31/2024 | $ 150.89M | $ -65.81M | -43.62% |
12/31/2023 | $ 166.82M | $ -66.07M | -39.6% |
9/30/2023 | $ 191.16M | $ -26.57M | -13.9% |
6/30/2023 | $ 123.16M | $ -56.09M | -45.54% |
3/31/2023 | $ 125.42M | $ -65.91M | -52.55% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net Inc. Cmn. / Equity
(=) ROE
ROE for ARDELYX INC is calculated as follows: Net Inc. Cmn. [ $ -85.23M ] / Equity [ $ 131.34M ]
(=) ROE [ -64.89% ]
Minimum
Jun 30, 2022
Maximum
Sep 30, 2023
Average
Median
filtered constituents | 3.14K |
---|---|
min | -66.79% |
max | 73.49% |
average | 1.52% |
median | 6.45% |
std | 22.72% |